MedPath

Filibuvir

Generic Name
Filibuvir
Drug Type
Small Molecule
Chemical Formula
C29H37N5O3
CAS Number
877130-28-4
Unique Ingredient Identifier
198J479Y2L
Background

Filibuvir has been used in trials studying the treatment of Hepatitis, Hepatitis C, and Chronic Hepatitis C.

Clinical Trials
Related News

Drug Interaction Study Of Filibuvir With Methadone Among Subjects On Chronic Methadone Maintenance

Phase 1
Completed
Conditions
Chronic Hepatitis C
Interventions
First Posted Date
2010-09-28
Last Posted Date
2011-06-07
Lead Sponsor
Pfizer
Target Recruit Count
12
Registration Number
NCT01210404
Locations
🇺🇸

Pfizer Investigational Site, Overland Park, Kansas, United States

Filibuvir In Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Subjects

Phase 2
Completed
Conditions
Hepatitis
Hepatitis C
Interventions
Drug: Placebo
First Posted Date
2009-09-30
Last Posted Date
2014-01-27
Lead Sponsor
Pfizer
Target Recruit Count
288
Registration Number
NCT00987337
Locations
🇪🇸

Pfizer Investigational Site, Sevilla, Spain

Investigation Of The Effect Of Steady State Filibuvir On The Pharmacokinetics Of Oral Contraceptives (Levonorgestrel And Ethinyl Estradiol)

Phase 1
Completed
Conditions
Hepatitis C
Interventions
First Posted Date
2009-06-11
Last Posted Date
2011-04-19
Lead Sponsor
Pfizer
Target Recruit Count
14
Registration Number
NCT00918476
Locations
🇧🇪

Pfizer Investigational Site, Bruxelles, Belgium

A Dose Ranging Study Of PF-00868554 In Combination With PEGASYS And COPEGUS In Patients With Chronic Hepatitis C Genotype 1 Infection

Phase 2
Completed
Conditions
Hepatitis C
Interventions
Drug: Placebo
First Posted Date
2008-07-22
Last Posted Date
2013-08-26
Lead Sponsor
Pfizer
Target Recruit Count
35
Registration Number
NCT00720434
Locations
🇵🇷

Pfizer Investigational Site, Santurce, Puerto Rico

A Phase 1 Study Of PF-00868554 In Hepatitis C Virus (HCV) Positive Patients

Phase 1
Completed
Conditions
Hepatitis C
Interventions
Drug: Placebo
First Posted Date
2007-03-08
Last Posted Date
2014-02-17
Lead Sponsor
Pfizer
Target Recruit Count
32
Registration Number
NCT00445315
Locations
🇬🇧

Pfizer Investigational Site, Dundee, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy